{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:49:03Z","timestamp":1778932143732,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Heart and Diabetes Centre North Rhine-Westphalia (DKZ NRW)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Electrical storm (ES) is associated with high mortality and may lead to worsening of heart failure or repeat ICD therapy deliveries. Catheter ablation of ventricular tachycardia (VT) in ischemic heart disease has proven to be successful in reducing ventricular arrhythmia recurrences. The prognostic impact of ablation on patients with ES needs to be further elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To analyse the impact of catheter ablation on prognostic outcomes in patients with electrical storm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A composite study endpoint consisting of all-cause death, implantation of a left ventricular assist device or heart transplantation was in consecutive patients who were admitted for ES therapy to our intensive-care unit from 2016 to 2022. Patients who underwent ablation were compared with propensity score-matched patients who underwent conservative treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Propensity-score matching of 155 patients with ES resulted in 51 patients undergoing catheter ablation and 51 patients with conservative therapy only with comparable baseline characteristics. A study endpoint event occurred in 18 patients (35%) in the ablation group and 34 patients (67%) in the conservative group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.015, Hazard ratio 2.06, 95%-CI 1.14\u20133.72) after a mean follow-up of 867\u2009\u00b1\u2009697 days. Ablation performed within 10 days after ES onset (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.04) and an increased ejection fraction (LVEF,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.024) were associated with a negative prediction of the occurrence of a primary endpoint by bivariate logistic regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Catheter ablation of ES was associated with a lower likelihood of death from any cause, LVAD implantation or heart transplantation as compared to conservative therapy alone, especially when performed timely after ES onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-026-02846-1","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T09:39:10Z","timestamp":1769420350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of catheter ablation on prognostic outcomes in electrical storm"],"prefix":"10.1007","author":[{"given":"Maximilian","family":"Moersdorf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Sohns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Sciacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Guckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian E.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha El","family":"Hamriti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Winnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moneeb","family":"Khalaph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim","family":"Didenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arseny","family":"Goncharov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guram","family":"Imnadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6665-7326","authenticated-orcid":false,"given":"Thomas","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"26","key":"2846_CR1","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1056\/NEJMoa065457","volume":"357","author":"VY Reddy","year":"2007","unstructured":"Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357(26):2657\u20132665. https:\/\/doi.org\/10.1056\/NEJMoa065457","journal-title":"N Engl J Med"},{"issue":"9708","key":"2846_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","volume":"375","author":"KH Kuck","year":"2010","unstructured":"Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacr\u00e9taz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS, VTACH study group (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375(9708):31\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(09)61755-4","journal-title":"Lancet"},{"issue":"31","key":"2846_CR3","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","volume":"141","author":"S Willems","year":"2020","unstructured":"Willems S, Tilz RR, Steven D, K\u00e4\u00e4b S, Wegscheider K, Gell\u00e9r L, Meyer C, Heeger CH, Metzner A, Sinner MF, Schl\u00fcter M, Nordbeck P, Eckardt L, Bogossian H, Sultan A, Wenzel B, Kuck KH, BERLIN VT Investigators (2020) Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial. Circulation 141(31):1057\u20131067. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043400","journal-title":"Circulation"},{"key":"2846_CR4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1161\/CIRCULATIONAHA.106.686534","volume":"117","author":"C Carbucicchio","year":"2008","unstructured":"Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, Riva S, Moltrasio M, Cireddu M, Veglia F, Della Bella P (2008) Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation 117:462\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.686534","journal-title":"Circulation"},{"issue":"8","key":"2846_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/eurheartj\/ehs453","volume":"34","author":"S Nayyar","year":"2013","unstructured":"Nayyar S, Ganesan AN, Brooks AG, Sullivan T, Roberts-Thomson KC, Sanders P (2013) Venturing into ventricular arrhythmia storm: a systematic review and meta-analysis. Eur Heart J 34(8):560\u2013571. https:\/\/doi.org\/10.1093\/eurheartj\/ehs453","journal-title":"Eur Heart J"},{"issue":"1","key":"2846_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.hrthm.2017.08.022","volume":"15","author":"P Vergara","year":"2018","unstructured":"Vergara P, Tung R, Vaseghi M, Brombin C, Frankel DS, Di Biase L, Nagashima K, Tedrow U, Tzou WS, Sauer WH, Mathuria N, Nakahara S, Vakil K, Tholakanahalli V, Bunch TJ, Weiss JP, Dickfeld T, Vunnam R, Lakireddy D, Burkhardt JD, Correra A, Santangeli P, Callans D, Natale A, Marchlinski F, Stevenson WG, Shivkumar K, Della Bella P (2018) Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival. Heart Rhythm 15(1):48\u201355. https:\/\/doi.org\/10.1016\/j.hrthm.2017.08.022","journal-title":"Heart Rhythm"},{"issue":"20","key":"2846_CR7","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.118.037997","volume":"139","author":"Y Komatsu","year":"2019","unstructured":"Komatsu Y, Hocini M, Nogami A, Maury P, Peichl P, Iwasaki YK, Masuda K, Denis A, Voglimacci-Stephanopoli Q, Wichterle D, Kawamura M, Fukamizu S, Yokoyama Y, Mukai Y, Harada T, Yoshida K, Yasuoka R, Igawa M, Ohira K, Shimizu W, Aonuma K, Kautzner J, Ha\u00efssaguerre M, Ieda M (2019) Catheter ablation of refractory ventricular fibrillation storm after myocardial infarction. Circulation 139(20):2315\u20132325. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037997","journal-title":"Circulation"},{"issue":"10","key":"2846_CR8","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.jacep.2024.05.032","volume":"10","author":"K Benali","year":"2024","unstructured":"Benali K, Ninni S, Guenancia C, Mohammed R, Decaudin D, Bourdrel O, Salaun A, Yvorel C, Groussin P, Pavin D, Vlachos K, Ja\u00efs P, Bouchet JB, Morel J, Brigadeau F, Laurent G, Klug D, Da Costa A, Haissaguerre M, Martins R (2024) Impact of catheter ablation of electrical storm on survival: a propensity score-matched analysis. JACC Clin Electrophysiol 10(10):2117\u20132128. https:\/\/doi.org\/10.1016\/j.jacep.2024.05.032","journal-title":"JACC Clin Electrophysiol"},{"key":"2846_CR9","doi-asserted-by":"publisher","unstructured":"Lin AY, Begur M, Margolin E, Brann A, Ho G, Han F, Hoffmayer K, Krummen DE, Raissi F, Urey M, Pretorius V, Adler ED, Feld GK, Hong KN, Hsu JC. Catheter ablation vs advanced therapy for patients with severe heart failure and ventricular electrical storm. Heart Rhythm. 2024 Sep 26:S1547\u20135271(24)03373\u20133. https:\/\/doi.org\/10.1016\/j.hrthm.2024.09.045. Epub ahead of print. PMID: 39332754","DOI":"10.1016\/j.hrthm.2024.09.045"},{"issue":"3","key":"2846_CR10","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/ehf2.15122","volume":"12","author":"M Cherbi","year":"2025","unstructured":"Cherbi M, Maury P, Benabou L, Faure M, Pozzi M, Sebbag L, Gandjbakhch E, Benali K, Groussin P, Rakza R, Martins RP, Delmas C (2025) Long-term outcomes of electrical storm patients listed for urgent heart transplantation but not transplanted acutely. ESC Heart Fail. 12(3):1583-1593 https:\/\/doi.org\/10.1002\/ehf2.15122","journal-title":"ESC Heart Fail"},{"issue":"3","key":"2846_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/europace\/eut304","volume":"16","author":"F Guerra","year":"2014","unstructured":"Guerra F, Shkoza M, Scappini L, Flori M, Capucci A (2014) Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis. Europace 16(3):347\u2013353. https:\/\/doi.org\/10.1093\/europace\/eut304","journal-title":"Europace"},{"issue":"2","key":"2846_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.eupc.2005.01.003","volume":"7","author":"KA Gatzoulis","year":"2005","unstructured":"Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, Sotiropoulos E, Zervopoulos G, Antoniou J, Brili S, Stefanadis CI (2005) Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 7(2):184\u201392. https:\/\/doi.org\/10.1016\/j.eupc.2005.01.003","journal-title":"Europace"},{"issue":"10","key":"2846_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.121.009853","volume":"14","author":"RP Martins","year":"2021","unstructured":"Martins RP, Maille B, Bessi\u00e8re F, Benali K, Guenancia C, Algalarrondo V, Gourraud JB, Baudinaud P, De Chillou C, Maury P, Sacher F, Galand V (2021) Left ventricular assist device implantation as a bailout strategy for the management of refractory electrical storm and cardiogenic shock. Circ Arrhythm Electrophysiol 14(10):e009853. https:\/\/doi.org\/10.1161\/CIRCEP.121.009853","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"21","key":"2846_CR14","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M, ESC Scientific Document Group (2022) 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 43(21):3997\u20134126. https:\/\/doi.org\/10.1093\/eurheartj\/ehac262","journal-title":"Eur Heart J"},{"issue":"1","key":"2846_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/europace\/euz132","volume":"21","author":"EM Cronin","year":"2019","unstructured":"Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, Aguinaga L, Leite LR, Al-Khatib SM, Anter E, Berruezo A, Callans DJ, Chung MK, Cuculich P, d\u2019Avila A, Deal BJ, Della Bella P, Deneke T, Dickfeld TM, Hadid C, Haqqani HM, Kay GN, Latchamsetty R, Marchlinski F, Miller JM, Nogami A, Patel AR, Pathak RK, S\u00e1enz Morales LC, Santangeli P, Sapp JL, Sarkozy A, Soejima K, Stevenson WG, Tedrow UB, Tzou WS, Varma N, Zeppenfeld K, ESC Scientific Document Group (2019) 2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace 21(1):1143\u20131144. https:\/\/doi.org\/10.1093\/europace\/euz132","journal-title":"Europace"},{"issue":"10","key":"2846_CR16","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/j.hrthm.2017.10.036","volume":"15","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL (2018) 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 15(10):e73\u2013e189. https:\/\/doi.org\/10.1016\/j.hrthm.2017.10.036","journal-title":"Heart Rhythm"},{"issue":"7","key":"2846_CR17","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jacc.2005.02.068","volume":"45","author":"AJ Kirtane","year":"2005","unstructured":"Kirtane AJ, Leder DM, Waikar SS, Chertow GM, Ray KK, Pinto DS, Karmpaliotis D, Burger AJ, Murphy SA, Cannon CP, Braunwald E, Gibson CM, TIMI Study Group (2005) Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. J Am Coll Cardiol 45(7):1781\u20136. https:\/\/doi.org\/10.1016\/j.jacc.2005.02.068","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2846_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078475","volume":"8","author":"C Donfrancesco","year":"2013","unstructured":"Donfrancesco C, Palleschi S, Palmieri L, Rossi B, Lo Noce C, Pannozzo F, Spoto B, Tripepi G, Zoccali C, Giampaoli S (2013) Estimated glomerular filtration rate, all-cause mortality and cardiovascular diseases incidence in a low risk population: the MATISS study. PLoS One (10):e78475. https:\/\/doi.org\/10.1371\/journal.pone.0078475","journal-title":"PLoS One"},{"issue":"11","key":"2846_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027359","volume":"6","author":"R Zhang","year":"2011","unstructured":"Zhang R, Zheng L, Sun Z, Zhang X, Li J, Hu D, Sun Y (2011) Decreased glomerular filtration rate is associated with mortality and cardiovascular events in patients with hypertension: a prospective study. PLoS ONE 6(11):e27359. https:\/\/doi.org\/10.1371\/journal.pone.0027359","journal-title":"PLoS ONE"},{"issue":"1","key":"2846_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10840-020-00924-6","volume":"63","author":"K Weidner","year":"2022","unstructured":"Weidner K, Behnes M, Schupp T, Hoppner J, Ansari U, Mueller J, Lindner S, Borggrefe M, Kim SH, Huseyinov A, Ellguth D, Akin M, Meininghaus DG, Bertsch T, Taton G, Bollow A, Reichelt T, Engelke N, Reiser L, Akin I (2022) Chronic kidney disease impairs prognosis in electrical storm. J Interv Card Electrophysiol 63(1):13\u201320. https:\/\/doi.org\/10.1007\/s10840-020-00924-6","journal-title":"J Interv Card Electrophysiol"},{"issue":"11","key":"2846_CR21","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00380-019-01415-z","volume":"34","author":"K Weidner","year":"2019","unstructured":"Weidner K, Behnes M, Wei\u00df C, Nienaber C, Reiser L, Bollow A, Taton G, Reichelt T, Ellguth D, Engelke N, Rusnak J, Schupp T, Kim SH, Barth C, Hoppner J, Akin M, Mashayekhi K, Borggrefe M, Akin I (2019) Impact of chronic kidney disease on recurrent ventricular tachyarrhythmias in ICD recipients. Heart Vessels 34(11):1811\u20131822. https:\/\/doi.org\/10.1007\/s00380-019-01415-z","journal-title":"Heart Vessels"},{"issue":"6","key":"2846_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00392-018-1396-y","volume":"108","author":"K Weidner","year":"2019","unstructured":"Weidner K, Behnes M, Schupp T, Rusnak J, Reiser L, Taton G, Reichelt T, Ellguth D, Engelke N, Bollow A, El-Battrawy I, Ansari U, Hoppner J, Nienaber CA, Mashayekhi K, Wei\u00df C, Akin M, Borggrefe M, Akin I (2019) Prognostic impact of chronic kidney disease and renal replacement therapy in ventricular tachyarrhythmias and aborted cardiac arrest. Clin Res Cardiol 108(6):669\u2013682. https:\/\/doi.org\/10.1007\/s00392-018-1396-y","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"2846_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.hrthm.2024.07.029","volume":"22","author":"M Miszczyk","year":"2025","unstructured":"Miszczyk M, Hoeksema WF, Kuna K, Blamek S, Cuculich PS, Grehn M, Molon G, Nowicka Z, van der Ree MH, Robinson CG, Sajdok M, Verhoeff JJC, Postema PG, Blanck O (2025) Stereotactic arrhythmia radioablation (STAR)-a systematic review and meta-analysis of prospective trials on behalf of the STOPSTORM.eu consortium. Heart Rhythm 22(1):80\u201389. https:\/\/doi.org\/10.1016\/j.hrthm.2024.07.029","journal-title":"Heart Rhythm"},{"key":"2846_CR24","doi-asserted-by":"publisher","unstructured":"Crico C, Blanck O, Miszczyk M, Grehn M, Mandija S, Schiappacasse L, Cvek J, Jadczyk T, Kristiansen SB, L\u00f3pez MA, De Ferrari GM, Postema PG, Fast MF, Pruvot E, Verhoeff JJC, Andratschke N, Blamek S, Perin M, De Panfilis L (2025) Ethical considerations of prospective data collection for stereotactic arrhythmia radioablation (STAR): an overview from the STOPSTORM.eu consortium. Strahlenther Onkol.\u00a0https:\/\/doi.org\/10.1007\/s00066-025-02480-2.\u00a0","DOI":"10.1007\/s00066-025-02480-2"},{"issue":"9","key":"2846_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf139","volume":"27","author":"F Sacher","year":"2025","unstructured":"Sacher F, Sarkozy A, P\u00fcrerfellner H, Steyer A, Lyne J, Coquard C, Tixier R, Combes N, Haissaguerre M, Efremidis M, Duchateau J, Castro Urda V, Martin CA, Lemoine M, Bergaz AC, Bogun F, Linton N, Derval N, Schlosser F, Pambrun T, Petru J, Hocini M, Pannone L, Mudroch M, Kautzner J, Jais P, Reichlin T, Neu\u017eil P, Peichl P (2025) Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the AFFERA ventricular arrhythmia ablation registry (AVAAR). Europace 27(9):euaf139. https:\/\/doi.org\/10.1093\/europace\/euaf139","journal-title":"Europace"},{"issue":"14","key":"2846_CR26","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1161\/CIRCULATIONAHA.118.038036","volume":"139","author":"S Viskin","year":"2019","unstructured":"Viskin S, Chorin E, Viskin D, Hochstadt A, Halkin A, Tovia-Brodie O, Lee JK, Asher E, Laish-Farkash A, Amit G, Havakuk O, Belhassen B, Rosso R (2019) Quinidine-responsive polymorphic ventricular tachycardia in patients with coronary heart disease. Circulation 139(14):2304\u20132314. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038036","journal-title":"Circulation"},{"issue":"10","key":"2846_CR27","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jacep.2021.03.024","volume":"7","author":"DL Li","year":"2021","unstructured":"Li DL, Cox ZL, Richardson TD, Kanagasundram AN, Saavedra PJ, Shen ST, Montgomery JA, Murray KT, Roden DM, Stevenson WG (2021) Quinidine in the management of recurrent ventricular arrhythmias: a reappraisal. JACC Clin Electrophysiol 7(10):1254\u20131263. https:\/\/doi.org\/10.1016\/j.jacep.2021.03.024","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"2846_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.hrcr.2020.03.005","volume":"6","author":"R Pinnelas","year":"2020","unstructured":"Pinnelas R, Friedman J, Gidea C, Yuriditsky E, Chinitz L, Cerrone M, Jankelson L (2020) The case for quinidine: management of electrical storm in refractory ventricular fibrillation. HeartRhythm Case Rep 6(7):375\u2013377. https:\/\/doi.org\/10.1016\/j.hrcr.2020.03.005","journal-title":"HeartRhythm Case Rep"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02846-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-026-02846-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02846-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T09:39:11Z","timestamp":1769420351000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-026-02846-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":28,"alternative-id":["2846"],"URL":"https:\/\/doi.org\/10.1007\/s00392-026-02846-1","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Boston Scientific and Medtronic. C. Sohns received lecture fees and is a consultant for Biosense Webster, Boston Scientific and Medtronic. All remaining authors have declared no conflicts of interest, TF received advisory fees from Boston Scientific. PS is member of the advisory board of Abbott, Biosense Webster.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}